Universe Pharmaceuticals (UPC) Receivables Refunds (2023 - 2025)
Universe Pharmaceuticals' Receivables Refunds history spans 3 years, with the latest figure at $1.0 billion for Q3 2025.
- On a quarterly basis, Receivables Refunds rose 115.24% to $1.0 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $1.0 billion, a 115.24% increase, with the full-year FY2025 number at $1.0 billion, up 115.24% from a year prior.
- Receivables Refunds hit $1.0 billion in Q3 2025 for Universe Pharmaceuticals, up from $475.3 million in the prior quarter.
- Over the last five years, Receivables Refunds for UPC hit a ceiling of $1.0 billion in Q3 2025 and a floor of $478899.0 in Q3 2023.
- Historically, Receivables Refunds has averaged $499.6 million across 3 years, with a median of $475.3 million in 2024.
- Biggest five-year swings in Receivables Refunds: soared 99154.96% in 2024 and later skyrocketed 115.24% in 2025.
- Tracing UPC's Receivables Refunds over 3 years: stood at $478899.0 in 2023, then soared by 99154.96% to $475.3 million in 2024, then soared by 115.24% to $1.0 billion in 2025.
- Business Quant data shows Receivables Refunds for UPC at $1.0 billion in Q3 2025, $475.3 million in Q3 2024, and $478899.0 in Q3 2023.